1.
JAMA Netw Open
; 5(3): e223073, 2022 03 01.
Article
in English
| MEDLINE | ID: covidwho-1750274
Subject(s)
COVID-19 Serological Testing , COVID-19 , COVID-19/diagnosis , Humans , SARS-CoV-2 , Workplace
2.
Int J Infect Dis
; 110: 232-234, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-1309248
ABSTRACT
We present two Delta (B.1.617.2) vaccine breakthrough individuals, a father and son living in separate households. The older, 63-year-old patient's symptoms were severe enough to require hospitalization. Despite having a high titer of anti-spike IgG in his serum, his symptoms resolved within 24 hours following monoclonal antibody (bamlanivimab/etesevimab) therapy.